 |
43 Diseases |  |
13 Trials |
|
13 Trials |  |
784 News |  |
| «123456789101112 |
- Trial initiation date: Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania (clinicaltrials.gov) - Jan 16, 2014
P4, N=120, Recruiting, Sponsor: Guiyun Xu
Initiation date: Jun 2013 --> Sep 2013
- Enrollment change: Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania (clinicaltrials.gov) - Jan 16, 2014
P4, N=120, Recruiting, Sponsor: Guiyun Xu
Initiation date: Jun 2013 --> Sep 2013 N=480 --> 120
- | Sediel (tandospirone) / Sumitomo Pharma, Pfizer
New P4 trial: TAAS: Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia (clinicaltrials.gov) - Jan 16, 2014
P4, N=100, Not yet recruiting, Sponsor: Qingyun Yin
- ziprasidone / Generic mfg.
Enrollment change: Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD) (clinicaltrials.gov) - Dec 29, 2013
P=N/A, N=45, Completed, Sponsor: Sheba Medical Center
N=480 --> 120 N=60 --> 45
- ziprasidone / Generic mfg.
Trial completion: Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD) (clinicaltrials.gov) - Dec 29, 2013
P=N/A, N=45, Completed, Sponsor: Sheba Medical Center
N=60 --> 45 Active, not recruiting --> Completed
- sertraline / Generic mfg., ziprasidone / Generic mfg.
Trial termination: Ziprasidone and Sertraline in PTSD (clinicaltrials.gov) - Dec 11, 2013
P2, N=7, Terminated, Sponsor: Universit
Active, not recruiting --> Completed Recruiting --> Terminated; High rate of early drop-outs
- sertraline / Generic mfg., ziprasidone / Generic mfg.
Enrollment change: Ziprasidone and Sertraline in PTSD (clinicaltrials.gov) - Dec 11, 2013
P2, N=7, Terminated, Sponsor: Universit
Recruiting --> Terminated; High rate of early drop-outs N=24 --> 7
- ||| ziprasidone / Generic mfg.
Enrollment change: Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State (clinicaltrials.gov) - Nov 18, 2013
P2, N=73, Completed, Sponsor: Tufts Medical Center
N=24 --> 7 N=100 --> 73
- Risperdal Consta (risperidone depot formulation) / J&J
Trial completion: Switching Medication to Treat Schizophrenia (clinicaltrials.gov) - Sep 29, 2013
P4, N=280, Completed, Sponsor: Mount Sinai School of Medicine
N=100 --> 73 Active, not recruiting --> Completed
- ziprasidone / Generic mfg.
Trial termination: Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder (clinicaltrials.gov) - Aug 9, 2013
P=N/A, N=1, Terminated, Sponsor: Mclean Hospital
Active, not recruiting --> Completed Recruiting --> Terminated; Clinical trial from which subjects were recruited closed to enrollment
- ziprasidone / Generic mfg.
Enrollment change: Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder (clinicaltrials.gov) - Aug 9, 2013
P=N/A, N=1, Terminated, Sponsor: Mclean Hospital
Recruiting --> Terminated; Clinical trial from which subjects were recruited closed to enrollment N=30 --> 1
- ziprasidone / Generic mfg.
Trial completion: Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes (clinicaltrials.gov) - Aug 5, 2013
P4, N=77, Completed, Sponsor: Veterans Medical Research Foundation
N=30 --> 1 Active, not recruiting --> Completed
- | New P4 trial: Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania (clinicaltrials.gov) - Jul 4, 2013
P4, N=120, Recruiting, Sponsor: Guiyun Xu
- || asenapine / Generic mfg.
Enrollment closed: An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308) (clinicaltrials.gov) - May 14, 2013
P=N/A, N=3000, Active, not recruiting, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting
- ziprasidone / Generic mfg.
Enrollment closed: Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs (clinicaltrials.gov) - May 2, 2013
P2, N=400, Active, not recruiting, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | New P4 trial: 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain (clinicaltrials.gov) - Apr 28, 2013
P4, N=80, Not yet recruiting, Sponsor: North Shore Long Island Jewish Health System
- | ziprasidone / Generic mfg.
Trial termination: One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome (clinicaltrials.gov) - Apr 22, 2013
P4, N=172, Terminated, Sponsor: Pfizer
Recruiting --> Active, not recruiting Completed --> Terminated; See Detailed Description
- ||| ziprasidone / Generic mfg.
Enrollment change: Geodon for the Treatment of Refractory Social Anxiety Disorder (clinicaltrials.gov) - Apr 15, 2013
P2, N=51, Completed, Sponsor: Duke University
Completed --> Terminated; See Detailed Description N=40 --> 51
- || olanzapine / Generic mfg., ziprasidone / Generic mfg.
Enrollment change: Pfizer/IVGTT/Ziprasidone/Olanzapine (clinicaltrials.gov) - Apr 10, 2013
P=N/A, N=120, Completed, Sponsor: Washington University School of Medicine
N=40 --> 51 N=250 --> 120
- | olanzapine / Generic mfg., ziprasidone / Generic mfg., clozapine / Generic mfg.
Enrollment change: Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus (clinicaltrials.gov) - Jan 29, 2013
P4, N=24, Completed, Sponsor: North Suffolk Mental Health Association
N=250 --> 120 N=40 --> 24
- ziprasidone / Generic mfg.
Enrollment change: Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (clinicaltrials.gov) - Jan 16, 2013
P3, N=0, Withdrawn, Sponsor: Pfizer
N=40 --> 24 N=153 --> 0
- || Clopixol (zuclopenthixol) / Lundbeck, Serlect (sertindole) / Lundbeck, Abbott
New P3 trial: Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis (clinicaltrials.gov) - Jan 8, 2013
P3, N=104, Recruiting, Sponsor: Fundaci
- | ziprasidone / Generic mfg.
Trial completion: Geodon in Weight Loss Study for Bipolar Disorders (clinicaltrials.gov) - Dec 10, 2012
P4, N=25, Completed, Sponsor: Stanford University
N=153 --> 0 Active, not recruiting --> Completed
- ziprasidone / Generic mfg.
Enrollment change: Predictors of Response to Augmentation With Ziprasidone (Geodon (clinicaltrials.gov) - Dec 9, 2012
P4, N=64, Completed, Sponsor: Tufts Medical Center
Active, not recruiting --> Completed N=50 --> 64
- ziprasidone / Generic mfg.
Trial completion: Predictors of Response to Augmentation With Ziprasidone (Geodon (clinicaltrials.gov) - Dec 9, 2012
P4, N=64, Completed, Sponsor: Tufts Medical Center
N=50 --> 64 Recruiting --> Completed
- galantamine hydrobromide / Generic mfg., citicoline / Generic mfg.
Trial completion: STAR-1: Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia (clinicaltrials.gov) - Nov 5, 2012
P2, N=43, Completed, Sponsor: Georgetown University
Recruiting --> Completed Recruiting --> Completed
- | aripiprazole / Generic mfg., ziprasidone / Generic mfg.
New P4 trial: Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome (clinicaltrials.gov) - Oct 23, 2012
P4, N=175, Completed, Sponsor: University of Malaya
- ziprasidone / Generic mfg.
Enrollment change: Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone (clinicaltrials.gov) - Oct 17, 2012
P=N/A, N=24, Completed, Sponsor: The University of Texas Health Science Center at San Antonio
Recruiting --> Completed N=36 --> 24
- ziprasidone / Generic mfg.
Trial completion: Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone (clinicaltrials.gov) - Oct 17, 2012
P=N/A, N=24, Completed, Sponsor: The University of Texas Health Science Center at San Antonio
N=36 --> 24 Active, not recruiting --> Completed
- | ziprasidone / Generic mfg.
Trial completion: 24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study (clinicaltrials.gov) - Jul 5, 2012
P=N/A, N=12, Completed, Sponsor: Centre for Addiction and Mental Health
Active, not recruiting --> Completed Active, not recruiting --> Completed
- paliperidone extended release / Generic mfg.
Enrollment change: POST: The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia (clinicaltrials.gov) - Apr 30, 2012
P4, N=43, Terminated, Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC
Active, not recruiting --> Completed N=580 --> 43
- Enrollment change: IMPACT: Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics (clinicaltrials.gov) - Apr 19, 2012
P4, N=132, Recruiting, Sponsor: Johns Hopkins University
N=580 --> 43 N=240 --> 132
- | ziprasidone / Generic mfg.
New P1 trial: Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions (clinicaltrials.gov) - Apr 18, 2012
P1, N=38, Completed, Sponsor: Dr. Reddy's Laboratories Limited
- ||| ziprasidone / Generic mfg.
New P1 trial: Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions (clinicaltrials.gov) - Apr 18, 2012
P1, N=56, Completed, Sponsor: Dr. Reddy's Laboratories Limited
- ||||||| ziprasidone / Generic mfg.
Trial completion, Monotherapy: Treatment of Major Depressive Disorder (MDD) With Ziprasidone (clinicaltrials.gov) - Mar 25, 2012
P3, N=61, Completed, Sponsor: Cedars-Sinai Medical Center
N=240 --> 132 Recruiting --> Completed
- ziprasidone / Generic mfg.
Trial completion: Pfizer Anxiety: Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) (clinicaltrials.gov) - Mar 15, 2012
P4, N=49, Completed, Sponsor: VA Palo Alto Health Care System
Recruiting --> Completed Recruiting --> Completed
- PK/PD data: PTN_POPS: Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (clinicaltrials.gov) - Jan 3, 2012
P=N/A, N=500, Recruiting, Sponsor: Daniel Benjamin
Recruiting --> Completed Not yet recruiting --> Recruiting
- | haloperidol / Generic mfg., ziprasidone / Generic mfg.
Trial initiation date: The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study (clinicaltrials.gov) - Dec 20, 2011
P3, N=876, Recruiting, Sponsor: Vanderbilt University
Not yet recruiting --> Recruiting Initiation date: Sep 2011 --> Dec 2011
- | haloperidol / Generic mfg., ziprasidone / Generic mfg.
Enrollment open: The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study (clinicaltrials.gov) - Dec 20, 2011
P3, N=876, Recruiting, Sponsor: Vanderbilt University
Initiation date: Sep 2011 --> Dec 2011 Not yet recruiting --> Recruiting
- ziprasidone / Generic mfg.
Enrollment change: An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression (clinicaltrials.gov) - Nov 20, 2011
P4, N=14, Completed, Sponsor: Queen's University
Not yet recruiting --> Recruiting N=32 --> 14
- ziprasidone / Generic mfg.
Trial completion: An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression (clinicaltrials.gov) - Nov 20, 2011
P4, N=14, Completed, Sponsor: Queen's University
N=32 --> 14 Recruiting --> Completed
- donepezil / Generic mfg., ziprasidone / Generic mfg.
Trial termination: The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia (clinicaltrials.gov) - Sep 18, 2011
P2, N=50, Terminated, Sponsor: Birte Glenthoj
Recruiting --> Completed No longer recruiting --> Terminated; No more funding